Abstract : Magnetic resonance spectroscopy (MRS) is proposed in addition to magnetic resonance imaging (MRI) to help in the characterization of brain tumours by detecting metabolic alterations that may be indicative of the tumour class. MRS can be routinely performed on clinical magnets, within a reasonable acquisition time and if performed under adequate conditions, MRS is reproducible and thus can be used for longitudinal follow-up of treatment. MRS can also be performed in clinical practice to guide the neurosurgeon into the most aggressive part of the lesions or to avoid unnecessary surgery, which may furthermore decrease the risk of surgical morbidity.
https://hal.inria.fr/hal-00805448
Contributeur : Olivier Colliot
<>
Soumis le : mercredi 27 mars 2013 - 19:47:53
Dernière modification le : lundi 27 août 2018 - 09:44:39
Virginie Callot, Damien Galanaud, Yann Le Fur, Sylviane Confort-Gouny, Jean-Philippe Ranjeva, et al.. (1)H MR spectroscopy of human brain tumours: a practical approach.. European Journal of Radiology, Elsevier, 2008, 67 (2), pp.268-74. 〈10.1016/j.ejrad.2008.02.036〉. 〈hal-00805448〉
